Synergy Rx Tirzepatide Review: Cost, Brand Access & Honest Verdict (2026)

Synergy Rx positions itself on access to clinicians rather than on price: unlimited appointments and messaging with a dedicated care team, and — genuinely distinctive in this category — providers who will prescribe FDA-approved brand tirzepatide (Mounjaro) when clinically appropriate, rather than defaulting straight to a compounded copy. The catch is transparency: this review's live check confirmed no GLP-1 price appears anywhere on Synergy Rx's public site, even though its longevity product line is priced openly on the same pages. Every fact here comes from the company's own published program.

What Synergy Rx is

Synergy Rx (synergyrx.co) is a telehealth platform whose stated differentiator is clinical access rather than the lowest sticker price. Its providers will prescribe FDA-approved brand medications — including Mounjaro — when clinically appropriate, and verbatim: "medications such as Wegovy®, Ozempic®, and Mounjaro®, when clinically appropriate." That's a genuine advantage over the many platforms in this category that only offer a compounded copy. Memberships are confirmed FSA and HSA eligible, and new patients are offered a $100 welcome credit applied at checkout.

The pricing gap worth knowing about before you sign up

This review's live check of Synergy Rx's public site found no GLP-1 or tirzepatide price anywhere — no dollar figure, no "starting at" range, nothing tied to the weight-loss line specifically. That's a meaningful gap: the same site prices its longevity product line openly (figures around $109 and $275 appear directly on the homepage for that separate category), which makes the absence of any GLP-1 number look like a deliberate choice rather than an oversight. If cost transparency before you commit to an intake matters to you, that's the single biggest thing to weigh against Synergy Rx's genuine brand-access advantage.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

Synergy Rx is one of the few providers in this ranking whose clinicians will prescribe the brand product specifically when appropriate, rather than compounded by default. The full legal picture on compounded tirzepatide's shrinking availability is in our guide to whether compounded tirzepatide is still legal in 2026; for the brand cash-price benchmark, see our Zepbound cost and savings guide.

How the care model holds up

Synergy Rx's real strengths: genuine brand Mounjaro access when clinically appropriate, FSA/HSA eligibility, and a $100 welcome credit. The trade-offs are equally real: no GLP-1 price appears anywhere on the public site, so the monthly cost is unknowable until you're inside the intake; this review also found no published state-coverage list and no published cancellation or refund terms anywhere on the pages checked. As with any GLP-1 program, get the all-in monthly figure in writing before you pay, and confirm cancellation terms directly; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Synergy Rx is worth considering specifically if brand-name Mounjaro access and unlimited clinical contact matter more to you than knowing the price before you start — but go in expecting to complete an intake before you learn what it costs, since this review's live check found no GLP-1 figure published anywhere on the site. If cost transparency up front is the priority, compare it against CoreAge Rx's published flat rate — but not Oak, which has the same problem in a different form: nine conflicting starting figures, none carrying a term, and no usable price until its intake is done. If genuine brand access is the priority and a published price matters too, weigh LifeMD instead; and if a broader longevity catalog with openly published entry pricing appeals to you, see RNK Health. For a brand-only platform with a genuinely verified LegitScript seal, see AskRx. See our best tirzepatide providers ranking for the full field.